GlassScriptPhysician profile
Tang Ho
NPI 1770755308
$4,431.00
in general payments reported to CMS, 2019-2025
21 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $889 · 2020: $162 · 2021: $563 · 2022: $1,495 · 2023: $487 · 2024: $660 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,322.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,197.01 | 2019-2022 | |
| Depuy Synthes Sales INC. | $740.62 | 2022-2024 | Trumatch, Na, Matrixcombo |
| Kls-Martin L.P. | $351.92 | 2021-2022 | |
| Medical Device Business Services, INC. | $247.65 | 2019-2022 | |
| Tactile Systems Technology INC | $221.49 | 2022 | |
| Abbvie INC. | $218.10 | 2023-2025 | |
| Mml US, INC. | $186.92 | 2022 | |
| Galderma Laboratories, L.P. | $172.51 | 2019-2023 | |
| Relievant Medsystems, INC. | $160.29 | 2023 | Intracept |
| Abbott Laboratories | $160.25 | 2022 | |
| Stryker Corporation | $146.84 | 2019 | |
| Medtronic, INC. | $136.15 | 2024 | Intellis Adaptivestim |
| Axogen | $129.36 | 2022-2025 | |
| Aerin Medical INC. | $120.47 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $109.39 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $24.25 | 2020 | |
| Checkpoint Surgical, INC | $23.77 | 2025 | Checkpoint Stimulators |
| Baudax Bio INC. | $22.28 | 2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $21.89 | 2024 | Clear+Brilliant |
| Smith+Nephew, INC. | $21.69 | 2021 | |
| Acell, INC. | $18.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tang Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.